Mucopolysaccharideosis, Gaucher, Fabry

Gene: NAGLU

Green List (high evidence)

NAGLU (N-acetyl-alpha-glucosaminidase)
EnsemblGeneIds (GRCh38): ENSG00000108784
EnsemblGeneIds (GRCh37): ENSG00000108784
OMIM: 609701, Gene2Phenotype
NAGLU is in 21 panels

2 reviews

Ellen McDonagh (Genomics England Curator)

Comment when marking as ready: Green gene, with a green review and is a confirmed gene on G2P for this phenotype. Mode of inheritance confirmed on G2P and OMIM.
Created: 29 Feb 2016, 6:07 p.m.

Helen Savage (Congenica Ltd)

Green List (high evidence)

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Mucopolysaccharidosis type IIIB

History Filter Activity

29 Feb 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

29 Feb 2016, Gel status: 4

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for NAGLU were set to Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920; Mucopolysaccharidosis, Type III; Mucopolysaccharidosis Type IIIB; Mucopolysaccharidosis Type III; MUCOPOLYSACCHARIDOSIS TYPE 3B

3 Aug 2015, Gel status: 4

Added New Source

Eik Haraldsdottir (Genomics England)

NAGLU was added to Mucopolysaccharideosis, Gaucher, Fabrypanel. Sources: UKGTN

3 Aug 2015, Gel status: 3

Added New Source

Eik Haraldsdottir (Genomics England)

NAGLU was added to Mucopolysaccharideosis, Gaucher, Fabrypanel. Sources: Emory Genetics Laboratory

3 Aug 2015, Gel status: 2

Set Mode of Inheritance

Eik Haraldsdottir (Genomics England)

Model of inheritance for gene NAGLU was changed to BIALLELIC, autosomal or pseudoautosomal

3 Aug 2015, Gel status: 2

Added New Source

Eik Haraldsdottir (Genomics England)

NAGLU was added to Mucopolysaccharideosis, Gaucher, Fabrypanel. Sources: Illumina TruGenome Clinical Sequencing Services

3 Aug 2015, Gel status: 1

Added New Source

Eik Haraldsdottir (Genomics England)

NAGLU was added to Mucopolysaccharideosis, Gaucher, Fabrypanel. Sources: Radboud University Medical Center, Nijmegen